Experimental studies investigating systemic immune activation and sepsis have demonstrated that pharmacological or genetic inhibition of IDO prevents depressive- and anxiety-like behaviors as well as cognitive deficits typically seen alongside acute inflammation (25–27). The gene discussed is IDO1; the disease is Sepsis.